BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND ARNT, HIF1BETA, 405, ENSG00000143437, P27540, HIF-1beta, HIF1B, TANGO AND Prognosis
10 results:

  • 1. Magnetic resonance imaging parameter-based machine learning for prognosis prediction of high-intensity focused ultrasound ablation of uterine fibroids.
    Zhang J; Yang C; Gong C; Zhou Y; Li C; Li F
    Int J Hyperthermia; 2022; 39(1):835-846. PubMed ID: 35764325
    [No Abstract]    [Full Text] [Related]  

  • 2. Aryl hydrocarbon receptor is a prognostic biomarker and is correlated with immune responses in cervical cancer.
    Wang J; Mijiti Y; Chen Y; Liu Z
    Bioengineered; 2021 Dec; 12(2):11922-11935. PubMed ID: 34784845
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prognostic value of an autophagy-related long-noncoding-RNA signature for endometrial cancer.
    Wang X; Dai C; Ye M; Wang J; Lin W; Li R
    Aging (Albany NY); 2021 Feb; 13(4):5104-5119. PubMed ID: 33534780
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Comparative analysis of the prognosis of patients with locally advanced cervical cancer undergoing laparoscopic or abdominal surgery].
    Xu YP; Wang ZQ; Liang XD; Wang Y; Wang JL
    Zhonghua Fu Chan Ke Za Zhi; 2020 Sep; 55(9):609-616. PubMed ID: 32957749
    [No Abstract]    [Full Text] [Related]  

  • 5. An organoid-based drug screening identified a menin-MLL inhibitor for endometrial cancer through regulating the HIF pathway.
    Chen J; Zhao L; Peng H; Dai S; Quan Y; Wang M; Wang J; Bi Z; Zheng Y; Zhou S; Liu Y; Chen C; Na F
    Cancer Gene Ther; 2021 Feb; 28(1-2):112-125. PubMed ID: 32632269
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Gender Disparity in Referral for Definitive Care of Malignant Pleural Effusions.
    Foote DC; Burke CR; Pandian B; Banks S; Haug KL; Hipp M; Zhao L; Smola B; Roh M; Carrott PW; Lynch WR; Chang AC; Lin J; Reddy RM
    J Surg Res; 2019 Dec; 244():409-416. PubMed ID: 31325663
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Identification of long non‑coding RNA expression patterns useful for molecular‑based classification of type I endometrial cancers.
    Ravo M; Cordella A; Saggese P; Rinaldi A; Castaldi MA; Nassa G; Giurato G; Zullo F; Weisz A; Tarallo R; Rizzo F; Guida M
    Oncol Rep; 2019 Feb; 41(2):1209-1217. PubMed ID: 30483802
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Hydatidiform mole and its complications: review of patient profiles and management at the university of the Philippines-Philippine General Hospital.
    Cagayan MS
    J Reprod Med; 2014; 59(5-6):235-40. PubMed ID: 24937963
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix.
    Nakanishi T; Ishikawa H; Suzuki Y; Inoue T; Nakamura S; Kuzuya K
    Gynecol Oncol; 2000 Nov; 79(2):289-93. PubMed ID: 11063659
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Selection of tumors with a poor prognosis in operable carcinoma of the endometrium.
    Muirhead W; Roberts JT
    Clin Radiol; 1978 Jan; 29(1):17-20. PubMed ID: 624196
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.